Page last updated: 2024-11-11

cyanobacterin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

cyanobacterin: isolated from freshwater cyanobacterium Scytonema hofmanni; has effect on nonphotosynthetic bacteria or protozoans & inhibits the growth of various algae; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6437843
MeSH IDM0104435

Synonyms (7)

Synonym
cyanobacterin
(3r,4r,5z)-3-[(7-chloro-1,3-benzodioxol-5-yl)methyl]-4-hydroxy-5-[(4-methoxyphenyl)methylidene]-4-propan-2-yloxolan-2-one
2(3h)-furanone, 3-((7-chloro-1,3-benzodioxo)-5-yl)methyl)dihydro-4-hydroxy-5-((4-methoxyphenyl)methylene)-4-(1-methylethyl)-, (3r,4r,5z)-rel-(+)-
80902-00-7
2(3h)-furanone, 3-((7-chloro-1,3-benzodioxol-5-yl)methyl)dihydro-4-hydroxy-5-((4-methoxyphenyl)methylene)-4-(1-methylethyl)-, (3alpha,4beta,5z)-(+)-
Q17189276
DTXSID001018202
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]